Kalehua Capital Management LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0002106181

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 Q2 2026 Q1 2026 Q4 2025

Q3 2026 · 22 positions · Total reported value $132.40M · Top-10 concentration 80.7% · Updated 2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

Turnover: 59.4% · 6 new · 3 cut · 10 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -20.5% · vs SPY -22.6% · Prev Value $173.96M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +3.1% · vs SPY +0.9% · Latest Value $132.40M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Kalehua Capital Management LLC disclosed 22 equity positions with a combined reported value of $132.40M. The filing implies a focused portfolio: its ten largest positions account for 80.7% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were MANE ($17.66M), BOXX ($17.58M), ANIX ($14.16M). By sector, the heaviest allocations are Health Care 81.7%, Other 18.3%.

Versus the prior quarter, Kalehua Capital Management LLC opened 6 new positions, trimmed 3 and fully exited 10, a turnover rate of 59.4% of positions. The portfolio's overlap with the prior quarter was 50% of names.

The largest new positions opened in Q3 2026 were ANIX ($14.16M), BETRF ($6.68M), VRDN ($5.72M).

Of the 10 positions fully exited versus the prior quarter, the largest were CMPS ($11.60M), SION ($8.67M), PHVS ($6.87M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • ANIX KORSANA BIOSCIENCES INC · $14.16M
  • BETRF BETTERLIFE PHARMA INC · $6.68M
  • VRDN VIRIDIAN THERAPEUTICS INC · $5.72M
  • ATOS ATTOVIA THERAPEUTICS INC · $3.43M
  • RNA ATRIUM THERAPEUTICS INC · $932.76K
  • KZIA KAZIA THERAPEUTICS LTD · $537.45K

Fully Exited (vs previous quarter)

  • CMPS COMPASS PATHWAYS PLC · prev qtr: $11.60M
  • SION SIONNA THERAPEUTICS INC · prev qtr: $8.67M
  • PHVS PHARVARIS N V · prev qtr: $6.87M
  • KPTI KARYOPHARM THERAPEUTICS INC · prev qtr: $6.70M
  • CYCN CYCLERION THERAPEUTICS INC · prev qtr: $5.60M
  • MLTX MOONLAKE IMMUNOTHERAPEUTICS · prev qtr: $3.42M
  • ANL ADLAI NORTYE GROUP LTD · prev qtr: $2.60M
  • TYRA TYRA BIOSCIENCES INC · prev qtr: $2.38M

Insider Transactions (Form 4)

Latest Kalehua Capital Management LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Kalehua Capital Management LLC is an SEC-registered 13F filer. As of Q2 2026 it reported 26 US equity positions with a combined value of $173.96M. HoldingsHub carries 3 quarters of its filings (Q4 2025–Q2 2026).

Portfolio Structure

  • 26 positions · $173.96M reported value (Q2 2026)
  • Top 10 holdings = 70.7% of reported value
  • Largest position: BOXX (ALPHA ARCHITECT 1-3 MONTH BOX ETF) at 15.2%
  • Average position size: $6.69M

Sector Tilt

  • Health Care 81.6%
  • (classified holdings cover 82% of value)

Quarterly Activity

  • Q2 2026: 8 new, 3 added, 2 reduced, 7 exited
  • 13 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund increased exposure to Health Care (90% of top-10 holdings), suggesting a bullish stance on biotech/therapeutics. No sector diversification beyond Health Care in top-10. 2. Key moves: - Added: ANIX (new, 10.70%), BETRF (new, 5.04%), VRDN (new, 4.32%)—total new positions ~20% of portfolio. - Reduced: BOXX (-34.4% shares, -1.94% wt), SRZN (-25.7% shares, but wt rose due to price). 3. Portfolio structure: Active (concentrated, 22 positions), high-risk (small/mid-cap biotech), Health Care–biased. 4. Per-holding one-liner: - MANE: VERADERMICS INC (dermatology biotech, unverified). - BOXX: EA SERIES TRUST ALPHA ARCH (ETF, unverified). - ANIX: ANIXA BIOSCIENCES (cancer immunotherapy, unverified). - XFOR: X4 PHARMACEUTICALS INC (osteosarcoma treatment, unverified). - ACRS: ACLARIS THERAPEUTICS INC (skin/hair disorders, unverified). - SRZN: Surrozen Inc (stem cell biology, unverified). - IKT: INHIBIKASE THERAPEUTICS INC (Parkinson’s, unverified). - SEPN: SEPTERNA INC (gastrointestinal disorders, unverified). - BETRF: BETTERLIFE PHARMA INC (pain therapeutics, unverified). - VRDN: VIRIDIAN THERAPEUTICS INC (thyroid disease, unverified). 5. Style summary: Concentrated Health Care fund betting on new biotech names while trimming some existing positions.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-15 04:59

Sector Allocation

Health Care 81.7%
Other 18.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 145.69K $17.66M 13.34%
13.34%
Hold
2 148.47K $17.58M 13.28%
13.28%
Reduce
3 442.65K $14.16M 10.70%
10.70%
New
4 3.72M $10.80M 8.15%
8.15%
Hold
5 1.83M $9.64M 7.28%
7.28%
Hold
6 286.09K $9.21M 6.95%
6.95%
Reduce
7 3.82M $7.85M 5.93%
5.93%
Hold
8 194.54K $7.61M 5.75%
5.75%
Hold
9 27.71M $6.68M 5.04%
5.04%
New
10 416.65K $5.72M 4.32%
4.32%
New
11 2.92M $5.26M 3.97%
3.97%
Add
12 473.60K $4.69M 3.54%
3.54%
Add
13 200.00K $3.43M 2.59%
2.59%
New
14 139.00K $2.96M 2.23%
2.23%
Hold
15 79.41K $1.92M 1.45%
1.45%
Hold
16 139.37K $1.65M 1.25%
1.25%
Reduce
17 1.65M $1.43M 1.08%
1.08%
Add
18 393.70K $1.41M 1.06%
1.06%
Hold
19 112.65K $932.76K 0.70%
0.70%
New
20 99.60K $721.10K 0.55%
0.55%
Hold
21 1.83M $554.34K 0.42%
0.42%
Add
22 56.01K $537.45K 0.41%
0.41%
New

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 60% R 60% F1 60% (modelled on 2026-Q2; 6/10 hit)

Low-confidence forecast This fund replaces about 30% of its Top-10 each quarter and backtests at F1 70% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (2 quarters)

Avg precision 70% · recall 70% · F1 70% · avg rank error 2.2 · Top-10 turnover 30%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2026-Q2 80% 80% 80% BOXX · XFOR · SRZN · MANE · RLAY · SION · IKT · ACRS · ORKA · PHVS BOXX · MANE · XFOR · CMPS · SRZN · ACRS · SION · IKT · PHVS · KPTI
2026-Q3 ★ 60% 60% 60% BOXX · MANE · XFOR · CMPS · SRZN · ACRS · IKT · SION · PHVS · KPTI MANE · BOXX · ANIX · XFOR · ACRS · SRZN · IKT · SEPN · BETRF · VRDN

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did Kalehua Capital Management LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, Kalehua Capital Management LLC reported 22 equity positions worth $132.40M in aggregate; its largest disclosed positions were MANE ($17.66M), BOXX ($17.58M), ANIX ($14.16M).

How large is Kalehua Capital Management LLC's portfolio?

Kalehua Capital Management LLC reported $132.40M of long equity holdings across 22 positions as of 2026-Q3. Top-10 holdings account for 80.7% of reported value.

What is Kalehua Capital Management LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/kalehua-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →